Literature DB >> 3723888

Effects of immunostimulation with OK432, coenzyme Q10, or levamisole on dimethylhydrazine-induced colonic carcinogenesis in rats.

H Suzuki, J Yamamoto, Y Iwata, K Matsumoto, K Iriyama.   

Abstract

Effects of immunostimulation with OK432, Coenzyme Q10 (Co-Q10), or levamisole on dimethylhydrazine (DMH)-induced colonic carcinogenesis were investigated in 45 Donryu-rats. The manipulation with one of these immunopotentiators did not prevent DMH-induced colonic carcinogenesis in these rats. However, the number of tumors was significantly reduced and the incidence of invasive carcinomas decreased by immunostimulation. The treatment also reduced the number of lesions with epithelial dysplasia within the flat colonic mucosa.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723888     DOI: 10.1007/bf02471087

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  3 in total

1.  General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part II. Histopathological classification. Japanese Research Society for Cancer of the Colon and Rectum.

Authors: 
Journal:  Jpn J Surg       Date:  1983-11

2.  Reduced incidence of rat colon cancer metastases by perioperative immunostimulation with maleic anhydride-divinyl ether-2 (MVE-2).

Authors:  J L Weese; E M Gilbertson; S E Syrjala; P D Whitney; J R Starling
Journal:  Dis Colon Rectum       Date:  1985-04       Impact factor: 4.585

Review 3.  Multimodal immunotherapy of primary gastrointestinal tumors in rats. 1. Histologic correlation.

Authors:  B R Bansal; J Mobini; S C Bansal
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

  3 in total
  1 in total

1.  Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3',4,4'-tetrachlorobiphenyl (PCB-77).

Authors:  Job C Tharappel; Hans-Joachim Lehmler; Cidambi Srinivasan; Larry W Robertson; Brett T Spear; Howard P Glauert
Journal:  Food Chem Toxicol       Date:  2008-08-30       Impact factor: 6.023

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.